18701results about "Biostatistics" patented technology

The technology disclosed assigns quality scores to bases called by a neural network-based base caller by (i) quantizing classification scores of predicted base calls produced by the neural network-based base caller in response to processing training data during training, (ii) selecting a set of quantized classification scores, (iii) for each quantized classification score in the set, determining a base calling error rate by comparing its predicted base calls to corresponding ground truth base calls, (iv) determining a fit between the quantized classification scores and their base calling error rates, and (v) correlating the quality scores to the quantized classification scores based on the fit.

Genome-wide data is obtained, and data cleansing, data sparsity processing and bioinformatics feature extraction are performed on the obtained genome-wide data; model construction is performed based on the sparsity-processed genome-wide data and the bioinformatics features to obtain a preliminary hybrid model; model training, regularization, and interpretability enhancement are performed on the preliminary hybrid model to obtain a trained model weight and an interpretability analysis corresponding to the trained model weight; learning and uncertainty estimation are performed based on the trained model weight and to-be-predicted genome-wide data on the hybrid model to obtain an integrated prediction result and uncertainties corresponding to the integrated prediction result; and personalized medical advice and decision assistance are performed based on the integrated prediction result, the interpretability analysis, and the uncertainties corresponding to the integrated prediction result.

A federated distributed computational system enables secure oncological therapy optimization through robotic integration. The system establishes a distributed graph architecture with secure communication channels connecting computational nodes, implementing encryption protocols for cross-institutional data exchange. Each node contains processing capabilities for fluorescence-guided imaging, uncertainty quantification, and expert knowledge integration while maintaining hierarchical knowledge graphs of oncological biomarkers, interventions, and outcomes. The system coordinates domain-specific knowledge through token-space communication and implements an advanced robotic integration system for surgical interventions using spatiotemporal tumor mapping, multi-modal fluorescence imaging, surgical robot coordination, and space-time stabilized mesh management. Key capabilities include wavelength-specific multi-modal fluorescence detection, combined epistemic and aleatoric uncertainty estimation, tensor-based data integration with adaptive dimensionality control, and light cone search for adaptive treatment optimization—all while maintaining strict privacy controls.

The AI-enhanced cellular modeling and simulation platform is a computational system designed to enhance biomedical research and development and personalized medicine and wellness. This platform integrates simulation modeling, machine learning and artificial intelligence, multi-omics data, and sophisticated data fusion and decision-support techniques to create comprehensive models of cellular systems and processes across multiple scales. It enables researchers and clinicians to simulate complex biological interactions, predict disease progression, and design or optimize treatment strategies or medical devices with improved accuracy and efficacy. The system's architecture allows for integration of various components, including real-time data processing, federated learning, and quantum computing enhancements. From personalized drug discovery and cancer therapies to synthetic biology and epidemiological analysis, this platform offers powerful tools for understanding and manipulating cellular systems and bioengineered systems. By bridging the gap between molecular-level interactions between cells and materials and organism-wide effects, it enables significant advancements in healthcare and biological sciences.

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.

An anomaly detection system is disclosed capable of reporting anomalous processes or hosts in a computer network using machine learning models trained using unsupervised training techniques. In embodiments, the system assigns observed processes to a set of process categories based on the file system path of the program executed by the process. The system extracts a feature vector for each process or host from the observation records and applies the machine learning models to the feature vectors to determine an outlier metric each process or host. The processes or hosts with the highest outlier metrics are reported as detected anomalies to be further examined by security analysts. In embodiments, the machine learnings models may be periodically retrained based on new observation records using unsupervised machine learning techniques. Accordingly, the system allows the models to learn from newly observed data without requiring the new data to be manually labeled by humans.

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.

A federated distributed computational system enables secure collaboration across multiple institutions for multi-species biological data analysis. The system consists of interconnected computational nodes managed by a central federation manager. Each node contains specialized components that work together to process multi-species biological data while preserving privacy. These components include a local computational engine that handles data processing, a physics-information integration subsystem that combines physical state calculations with information-theoretic optimization, a privacy preservation module that protects sensitive information, a knowledge integration component that manages biological data relationships, and a communication interface that enables secure information exchange between nodes. The federation manager coordinates all computational activities and manages resource allocations across the network while ensuring data privacy is maintained throughout the process. This architecture allows research institutions to collaboratively analyze complex, multi-species biological systems through integrated physics-based modeling and information-theoretic approaches while maintaining security and confidentiality.

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.

A multi-source data fusion method and apparatus, and an electronic device and a storage medium. The method comprises: taking multi-source data as different pieces of modal data; respectively constructing sub-hypergraphs; splicing the sub-hypergraphs into a hypergraph; then performing representation learning on a pre-constructed hypergraph neural network model according to the hypergraph, so as to obtain biological data node representations; and predicting an unknown or unobserved association relationship or interaction relationship according to the biological data node representations, so as to realize the construction of the relevance between biological nodes. The relevance makes data of different sources be fused together; the relevance is scored to obtain a prediction score, so as to determine the strength of the relevance; and finally, the hypergraph neural network model is repeatedly trained according to specific downstream tasks, and when a loss function converges, a satisfactory prediction result is obtained, such that fusion of multi-source data is realized.

The invention discloses an identification method and system of a short antibacterial peptide sequence, a terminal and a storage medium. Relates to the technical field of bioinformatics. A short antibacterial peptide data set is obtained in advance, a training set is obtained through division according to the short antibacterial peptide data set, and a pre-trained protein language model is finely adjusted according to the training set; obtaining sequence features of a to-be-classified sequence through the fine-tuned protein language model; obtaining physicochemical characteristics of the to-be-classified sequences through an analysis method based on pseudo amino acid components; inputting the sequence features and the physicochemical features into an attention model for feature fusion to obtain fusion features of the to-be-classified sequence; and inputting the fusion features into a classifier to obtain a prediction category of the to-be-classified sequence. According to the method, the pre-training model is finely adjusted by establishing a more perfect short antibacterial peptide data set, the sequence features and the physicochemical features of the to-be-classified sequences are fused, and the sequences are classified through the fused features, so that the recognition accuracy of the short antibacterial peptides can be effectively improved.

A federated distributed computational system enables secure oncological therapy optimization through multi-expert integration and advanced uncertainty quantification. The system implements a multi-expert integration framework that coordinates domain-specific knowledge through token-space communication for precision oncological treatment, while maintaining secure cross-institutional data exchange. The architecture coordinates multi-scale spatiotemporal synchronization across computational nodes, with each node containing local processing capabilities for fluorescence-guided imaging, uncertainty quantification, and expert knowledge integration. Through a distributed graph architecture, the system enables advanced fluorescence imaging with wavelength-specific targeting, multi-level uncertainty estimation combining epistemic and aleatoric approaches, and multi-scale tensor-based integration with adaptive dimensionality control. The system implements light cone search and planning for adaptive treatment strategy optimization, enabling medical institutions and research organizations to collaborate on complex oncological therapy projects while maintaining strict data privacy controls.

An anomaly detection system is disclosed capable of reporting anomalous processes or hosts in a computer network using machine learning models trained using unsupervised training techniques. In embodiments, the system assigns observed processes to a set of process categories based on the file system path of the program executed by the process. The system extracts a feature vector for each process or host from the observation records and applies the machine learning models to the feature vectors to determine an outlier metric each process or host. The processes or hosts with the highest outlier metrics are reported as detected anomalies to be further examined by security analysts. In embodiments, the machine learnings models may be periodically retrained based on new observation records using unsupervised machine learning techniques. Accordingly, the system allows the models to learn from newly observed data without requiring the new data to be manually labeled by humans.

A federated distributed computational system enables secure, multi-institutional biological data analysis and genomic medicine through interconnected, decentralized nodes in a federated distributed graph architecture. A federation manager coordinates computational resource allocation, control and data flows, establishes privacy and security boundaries, implements multi-scale spatiotemporal analysis and simulation modeling, models cross-species or intrapopulation elements, and maintains cross-institutional knowledge relationships. Each node includes a local processing unit for biological data analysis, including multiomics and gene editing, privacy-preserving protocols for secure multi-party computation, a hierarchical knowledge graph for managing multi-domain biological relationships across spatial and temporal scales, and encrypted network connections. The system implements cross-species genetic analysis via phylogenetic integration, environmental response modeling through spatiotemporal tracking, and multi-scale tensor-based data integration with adaptive dimensionality control. This architecture enables research institutions to collaborate on complex biological analyses and genomic medicine applications while maintaining strict data privacy and security controls.

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.

A federated distributed computational system enables secure biological data analysis and genomic medicine through hybrid simulation capabilities. The system implements a hybrid simulation orchestrator that coordinates classical numerical simulations with machine learning models for biological system analysis, while maintaining secure cross-institutional data exchange. The architecture coordinates multi-scale spatiotemporal synchronization across computational nodes, with each node containing local processing capabilities for biological data analysis and privacy preservation protocols. The system implements cellular machinery assembly analysis, real-time patient data integration, and multi-modal image integration with spatiotemporal health data annotation. Through a distributed graph architecture, the system enables cross-species genetic analysis, environmental response modeling, and multi-scale tensor-based data integration with adaptive dimensionality control. The system implements real-time therapeutic response prediction through multi-modal data analysis, enabling research institutions to collaborate on complex biological analyses while maintaining strict data privacy controls.

The invention relates to the technical field of cell culture, in particular to an artificial intelligence-based cell culture synchronous control system, which comprises a data acquisition module, a data processing module, an intelligent prediction module, a control strategy generation module, an execution mechanism control module, a feedback regulation module and a user interaction module, the data acquisition module acquires environmental parameters in a culture environment in real time, the data processing module preprocesses the acquired environmental parameters, the intelligent prediction module predicts the change trend of the culture environment in future time by using a machine learning algorithm, and the control strategy generation module generates a cell culture control strategy. The execution mechanism control module converts the control strategy into an execution instruction, the feedback adjustment module monitors the effect of the execution instruction and adjusts the control strategy according to feedback information, and the user interaction module provides a user interaction interface. According to the invention, through comprehensive real-time monitoring, intelligent prediction, optimal control and real-time feedback adjustment, the precision, efficiency and safety of cell culture are improved.

The invention discloses a benign and malignant nodule grading evaluation system based on large model fusion ultrasonic imaging and thyroid gene markers, which can organically fuse non-invasive examination and serological detection, can simulate and diagnose multi-grade risk probability information provided by a gold standard, realizes similar risk grading estimation in a non-invasive mode, and has a wide application prospect. The thyroid nodule risk assessment method can provide visual explanation conforming to clinical logic based on comprehensive information of iconography and molecular biology, can significantly improve the accuracy of thyroid nodule risk assessment, can also effectively improve clinical decision-making efficiency and patient credibility, and has important clinical application prospects. The system comprises a data acquisition module, an ultrasonic image feature extraction module, a gene marker feature extraction module, a multi-modal fusion and hierarchical reasoning module and a generation module.

The invention provides a water pollutant traceability method based on environmental DNA and machine learning. The method comprises the following steps: S1, investigating and surveying a regional pollutant source and representing water characteristics; s2, environment DNA extraction, specific primer amplification and DNA sequencing quantification; s3, constructing and training a machine learning model by using the DNA data and the water quality data; and S4, collecting a water sample in an actual pollution area, inputting data to the model, and outputting a pollution source type and a proportion. According to the method, the environment DNA technology and the machine learning model are combined, the water pollutant tracing method which is suitable for various pollution sources, accurate and efficient is innovatively provided, and the method has high application value and wide popularization prospects.

The invention discloses a genomics-based Parkinson's disease drug target prediction model construction method, and relates to the technical field of drug research and development, and the method comprises the following steps: collecting genomics, transcriptomics and proteomics data related to Parkinson's disease patients, and carrying out quality control and standardization processing; through differential expression analysis and function enrichment, key genes and signal pathways related to Parkinson's disease are identified, and a potential drug target range is determined. By integrating genomics, transcriptomics and proteomics data of patients with Parkinson's disease, molecular mechanisms related to Parkinson's disease can be comprehensively analyzed, multi-target combination is optimized in combination with the ant colony algorithm, the limitation that a traditional single-target model is difficult to capture complex disease network comprehensiveness is effectively overcome, and the method is suitable for popularization and application. The accuracy of target spot prediction is remarkably improved, a more reliable action target spot is provided for drug research and development, and the failure rate of clinical tests is reduced.

The invention relates to the technical field of seed processing analysis, in particular to a big data-based rape seed quality evaluation model, which is characterized in that a data pool is constructed by converging multi-source heterogeneous rape data, and high-quality input is provided for subsequent cross-domain feature association; a cross-domain feature interaction graph is constructed, a graph neural network is used for learning, cross-domain feature interaction is visually presented, and a gene-environment interaction relationship is analyzed; through a four-branch multi-head and cross-modal attention analysis atlas, focusing key features, fusing optimization information and generating a high-quality feature vector, high-order feature nonlinear fusion is realized, and the characterization capability of the model on multi-source heterogeneous data is remarkably improved; an evaluation model is constructed through decoding vectors, and high-yield variety data is extracted, so that efficient screening of rape varieties is facilitated; by deploying the generative adversarial network and transferring the learning adaptive model, the evaluation capability is quickly expanded to a new variety, and breeding intelligence is promoted.

The invention relates to the technical field of biological information, in particular to a stem cell culture information management method and system. The method comprises the following steps: collecting culture process basic data in a stem cell culture process, wherein the culture process basic data comprises cell counting data, culture condition parameter data and pollution condition data; performing growth kinetic analysis on the basic data in the culture process to obtain cell growth characteristic data; establishing a cell growth prediction model based on the cell growth characteristic data, and generating cell growth early warning data; and monitoring the culture process in real time according to the cell growth early warning data, triggering an early warning signal when abnormal fluctuation is detected, and generating a culture abnormality processing scheme. The growth prediction model is established based on the cell growth characteristic data, the culture dynamic state can be monitored in real time, an early warning signal is provided, the detection and response speed of abnormal fluctuation is remarkably improved, and culture failure is avoided.

Methods and systems for performing in situ decoding are described that minimize optical crowding, thereby improving decoding accuracy. The methods may comprise, e.g., receiving images of a biological sample acquired during a cyclical decoding process; detecting a series of detectable signals (ON signals) or absence thereof (OFF signals) at one or more locations in the biological sample corresponding to one or more barcoded target analytes; determining a code word based on the series of ON and OFF signals that corresponds to a barcode for each of the one or more barcoded target analytes, where the one or more code words are assigned to the one or more barcoded target analytes based on a minimax decision rule to minimize a density of ON signals detected in the images of the series of images; and identifying the one or more barcoded target analytes based on the one or more determined code words.

The invention relates to the technical field of medical data processing, in particular to a risk assessment system for chronic diseases. The system is used for performing physiological index analysis according to a medical physiological monitoring signal to generate physiological index data; performing individual physiological index weight empowerment on the physiological index data based on genomics data to obtain individual physiological index data; performing quantitative analysis on pathological influence factors of chronic disease types according to the electronic health record data and the individual physiological index data, and generating individual chronic disease influence factor quantitative data; performing composite interaction risk factor analysis on the individual chronic disease influence factors based on the quantitative data of the individual chronic disease influence factors to generate individual chronic disease composite interaction risk factor data; and performing individual chronic disease risk assessment based on the individual chronic disease composite interaction risk factor data to generate individual chronic disease risk assessment data. According to the invention, chronic disease health management and accurate evaluation are realized through collaborative evaluation work of chronic disease risks.

The invention relates to the field of drug-target affinity prediction, in particular to a drug-target affinity prediction method based on a multi-scale mixed attention network. According to the method, global residue characteristics can be learned by protein pocket residues by utilizing a self-attention mechanism, so that the global characteristics of the protein are learned. In addition, a cross-modal feature fusion mechanism is utilized, protein and drug structural features are enhanced in sequence features, cross-modal feature fusion in entities is enhanced, meanwhile, a cross-entity interaction module is utilized to recognize key atoms of drug molecules or key residues of protein, and therefore the overall performance of the model is improved. Finally, multi-level protein feature extraction is further introduced to further extract protein features.

The invention relates to the field of drug target interaction, and discloses an application of a multi-modal feature fusion model in drug target binding affinity prediction, which comprises the following steps: S1, obtaining an original data set of drug target binding affinity, and taking a binding affinity index in the data set as a label of a training set and a test set; s2, acquiring representation information of other modals by using the drug sequence and target sequence representation provided in the original data set, preprocessing the acquired representation information of drugs and targets in different modals, and processing the representation information into a model acceptable feature vector form; and S3, respectively storing the multi-modal feature vectors of the drug and the target as well as the binding affinity tags in a form of pytorchsensor (. Pt). According to the method, shallow characterization of the drug and protein sequences is learned by applying the pre-training model, and the problem that a drug target binding affinity data set is insufficient is solved.

The invention relates to the technical field of artificial intelligence, and particularly provides a KASP primer intelligent typing evaluation method and system TAL-SRX based on multi-model fusion. The method comprises the following steps: firstly, optimizing the performance of a basic model and a meta model by using RS, PSO and BO algorithms, constructing a Stacking integrated learning framework to integrate the advantages of an XGBoost learner, and enhancing the stability of the model by adopting five-fold cross validation; then, combining ANN and LSTM to construct a hybrid neural network, capturing a nonlinear relationship and extracting complex features, and meanwhile, introducing a Transform algorithm to capture a global dependency relationship in a high-dimensional feature space; and finally, fusing the two machine learning algorithms through a soft voting integration strategy, and outputting a KASP mark typing effect score. According to the method, the KASP marker with an excellent typing effect can be accurately screened, relatively high robustness and good and reliable evaluation performance are achieved, and technical support is provided for work such as molecular marker-assisted breeding.

The invention relates to the technical field of breeding planning, in particular to an intelligent breeding planning and decision-making method and system based on a large model. The method comprises the following steps: acquiring a multi-source breeding data set; constructing a structured breeding knowledge graph based on the multi-source breeding data set; performing breeding data association on the structured breeding knowledge graph according to a preset large model to generate a special breeding basic model; obtaining a breeding instruction input by a user; performing user semantic recognition on a breeding instruction input by a user to generate breeding semantic recognition data; inputting the breeding semantic recognition data into a breeding special basic model for breeding intention analysis, and generating user breeding intention data; and determining data information needing to be called based on the breeding intention data of the user, analyzing and screening to generate germplasm resource screening data and a breeding plan / breeding decision scheme. According to the method, the intelligence and operability of breeding planning are improved through integration of multi-source data, intelligent semantic recognition, combined genetic analysis and executable evaluation.